Overactive Bladder Common in Postacute COVID-19 Syndrome
COVID-19 may lead to new or worsening urinary symptoms in men and women
COVID-19 may lead to new or worsening urinary symptoms in men and women
A randomized phase 3 trial revealed no significant difference in disease-free survival between extended and standard lymph node dissection during radical cystectomy for muscle-invasive urothelial…
Accelerated aging associated with increased risk for early-onset tumors, driven by lung, gastrointestinal, uterine cancers
Kidney or ureteral stones are larger and more likely to be symptomatic at presentation.
A phase 3 trial demonstrates a high rate of complete response with cretostimogene, an investigational immunotherapy administered intravesically.
Compared with oncologists, urologists report more barriers to using standard of care treatment intensification in the first-line setting for metastatic
The geographic distribution of the malignancy in Finland provided a clue to an upward trend.
Increased levels can cause harm, but clinicians can help their patients focus on nourishing their body rather than fearing nutrients by staying current on guidelines…
DD01 is a long-acting dual agonist of glucagon-like peptide-1 and glucagon receptors.
Adding the radionuclide therapy ¹⁷⁷Lu-PSMA-617 to enzalutamide improved outcomes in patients with treatment-naïve mCRPC in a phase 2 trial.
Investigators assessed the monosodium urate burden using 2 ultrasound scoring systems among patients with gout and compared their ability to predict flares.